Tizanidine Tablet
Product Images NDC 71335-1016

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 71335-1016). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tizanidine-1 (Tizanidine 1)

Chemical structure of Tizanidine hydrochloride. The diagram displays the molecular framework with chlorine, nitrogen, sulfur, and hydrogen atoms arranged in its characteristic heterocyclic structure.*

FDA Label Image

Tizanidine-2 (Tizanidine 2)

A pharmacokinetic line graph showing plasma concentration (ng/mu) of 4 mg tizanidine over time (hours from dosing). The graph compares tizanidine tablets and capsules taken with and without food, illustrating concentration changes from 0 to 26 hours post-dose.*

FDA Label Image

Tizanidine-3 (Tizanidine 3)

A line graph showing the improvement in Ashworth Score over 6 hours post-dose. It compares three lines representing 16 mg tizanidine, 8 mg tizanidine, and placebo, illustrating changes in muscle tone improvement scores over time.*

FDA Label Image

Tizanidine-4 (Tizanidine 4)

A graph comparing improvement in Ashworth Score over time between tizanidine (mean dose 28.8 mg) and placebo groups. The y-axis shows improvement scores from 2 to -6, and the x-axis marks study time points: End of Titration (Week 3), End of Maintenance (Week 7), and Endpoint (Last Observation Carried Forward). Tizanidine shows greater improvement with mean scores below zero, while placebo scores remain near zero or above.*

FDA Label Image

Label Image (Lbl713351016)

Label for Tizanidine 4 mg tablet by Bryant Ranch Prepack. The label includes storage instructions at 20°-25°C (68°-77°F), a warning about dizziness or drowsiness, a note comparing to Zanaflex 4 mg tablet by ALKALOIDA chemical company Zrt, and an NDC number 71335-1016-1. It also displays a barcode, lot number, and quantity of 30 tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.